One previous study in the Korean population suggested that the ERCC2 rs50872 TT genotype was associated with a significantly poorer response and a poor prognostic factor in 129 NSCLC patients without surgery but treated with platinum‐based chemotherapy 13. Here, ERCC2 is linked to non-small cell lung carcinoma.